# The NIPA Study Naloxegol Administration to Prevent Opioids Induced Gastrointestinal Motility Disturbance in Brain Injured PAtients

> **NCT05008926** · PHASE3 · RECRUITING · sponsor: **University Hospital, Brest** · enrollment: 370 (estimated)

## Conditions studied

- Brain Injuries

## Interventions

- **DRUG:** Naloxegol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05008926
- **Lead sponsor:** University Hospital, Brest
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-03-15
- **Primary completion:** 2026-03-15
- **Final completion:** 2026-09-15
- **Target enrollment:** 370 (ESTIMATED)
- **Last updated:** 2025-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05008926

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05008926, "The NIPA Study Naloxegol Administration to Prevent Opioids Induced Gastrointestinal Motility Disturbance in Brain Injured PAtients". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT05008926. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*